Benevir Biopharm, Inc.

Baltimore, MD 21224

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $223K
First Award Date 09/13/12
Most Recent Award Date 09/13/12

Key Personnel

Last Name Name Awards Contact
Mulvey Matthew Charles Mulvey 1

1 Award Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 09/13/12 - 08/31/13

DESCRIPTION (provided by applicant): Oncolytic virus (OV) therapies for cancer employ a dual mechanism of action and have two major advantages. First, OV are attenuated and designed to efficiently replicate in and kill only cancer cells, creating a large safety profile. Second, as observed in animal models and human trials, OV replication and s...